Home › Funds › VanEck ETF Trust › VanEck Healthcare TruSector ETF
Fund family: VanEck ETF Trust · Filed by VanEck ETF Trust (CIK 1137360) · SEC series S000099627
Ticker: TRUH (C000269404)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 51 with, 1 against, 0 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as VanEck ETF Trust’s manager page (28,640 ballot items across 55 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | VanEck ETF Trust | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 90.2% | 51 | 89.2% | 21,516 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 16.2% | 309 |
No item-level comparison with other VanEck ETF Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 52 such votes could be given a sector.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 52 | 1 | 1.9% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 41 | 0 |
| Audit-related | 5 | 0 |
| Say-on-Pay | 5 | 0 |
| Corporate Governance | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| UnitedHealth Group Incorporated | June 1, 2026 | $36,261 | 12 | 1 |
| Regeneron Pharmaceuticals, Inc. | June 12, 2026 | $9,524 | 7 | 0 |
| Biogen Inc. | June 9, 2026 | $3,523 | 12 | 0 |
| Incyte Corporation | June 8, 2026 | $1,924 | 10 | 0 |
| DaVita Inc. | June 4, 2026 | $697 | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | For | Against |
52 ballot items at 5 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, VanEck Healthcare TruSector ETF (TRUH) voted at 5 shareholder meetings of 5 companies, on 52 ballot items in all. Where management made a recommendation, the fund followed it on 98.1% of the items and voted against it 1 time. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 1 shareholder proposal. It voted FOR the board's own proposals more often than VanEck ETF Trust's funds as a whole (90.2% against 89.2%).
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of VanEck ETF Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.